CurrentRegence BlueCross BlueShieldPolicy 83.04

Functional Neuromuscular Electrical Stimulation

Customize your policy alerts

Sign up for regence Policy 83.04 alerts

Get alerted when Policy 83.04 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

This policy governs coverage of functional neuromuscular electrical stimulation devices and techniques, including NMES, FNS, FES, ENS, and EMG-triggered stimulation, for all indications and related DME uses.

Policy Summary

PayerRegence BlueCross BlueShield

PolicyFunctional Neuromuscular Electrical Stimulation

Policy CodePolicy 83.04

Change TypeNo material change

Effective DateNovember 1, 2026

Last ReviewSep 1, 2026

Next Review DateNovember 1, 2027

Key ActionAdvise that coverage is denied because functional neuromuscular electrical stimulation is investigational for all indications.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

All indicationsCoverage status

5 typesStimulation types included

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentRegence BlueCross BlueShieldPolicy 83.04

Functional Neuromuscular Electrical Stimulation

Customize your policy alerts

Sign up for regence Policy 83.04 alerts

Get alerted when Policy 83.04 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerRegence BlueCross BlueShield

PolicyFunctional Neuromuscular Electrical Stimulation

Policy CodePolicy 83.04

Change TypeNo material change

Effective DateNovember 1, 2026

Last ReviewSep 1, 2026

Next Review DateNovember 1, 2027

Key ActionAdvise that coverage is denied because functional neuromuscular electrical stimulation is investigational for all indications.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

All indicationsCoverage status

5 typesStimulation types included

Coverage Criteria

All Functional Neuromuscular Electrical Stimulation

Functional neuromuscular electrical stimulation using any device is considered investigational for all indications.

Investigational status: The requested functional neuromuscular electrical stimulation device or technique is investigational and therefore not covered, regardless of indication.

Applies to all devices and all indications.

NMES for Other Conditions

Evidence summary for NMES in other conditions.

Evidence conclusion: Current studies do not demonstrate improved health outcomes from NMES for other conditions, including but not limited to COPD, edema, peripheral artery disease, or spasticity.

Additional randomized controlled trials comparing NMES with standard treatment are required.

NMES Cycling

Evidence summary for EMG-triggered NMES plus cycling.

Evidence conclusion: It is not clear that benefits achieved with EMG-triggered NMES plus cycling cannot be realized through standard passive range-of-motion exercise.

The feasibility and long-term benefits of NMES cycling are uncertain; additional randomized controlled trials comparing this therapy with standard treatment are required.

All Indications

Functional NMES is considered investigational for all indications.

Investigational status: Functional neuromuscular electrical stimulation is considered investigational for all indications, including but not limited to spinal cord injury, stroke, congenital disorders, nerve damage, and pain.

No covered indication is identified in this section.

Functional neuromuscular electrical stimulation using any device is considered investigational and is not covered for ambulation in individuals with spinal cord injury, restoration of upper- or lower-extremity function after nerve damage or stroke, improvement of ambulation for foot drop caused by congenital disorders or nerve damage, or treatment of pain.

Functional NMES is considered investigational for all indications, including spinal cord injury, stroke, congenital disorders, nerve damage, pain, and other conditions. The available research has not established improved health outcomes, and additional randomized controlled trials comparing NMES with standard treatment are needed.

HCPCS Coding

HCPCS codesHCPCS

A4560	Neuromuscular electrical stimulator (NMES), disposable, replacement only.
E0490	Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by hardware remote.
E0493	Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply.

HCPCS codesHCPCS

E0731	Form fitting conductive garment for delivery of TENS or NMES (with conductive fibers separated from the patient's skin by layers of fabric).
E0744	Neuromuscular stimulator for scoliosis.
E0745	Neuromuscular stimulator, electronic shock unit.
E0764	Functional neuromuscular stimulator, transcutaneous stimulation of muscles of ambulation with computer control, used for walking by spinal cord injured, entire system after completion of training program.
E0770	Functional electrical stimulator, transcutaneous stimulation of nerve and/or muscle groups, any type, complete system, not otherwise specified.

Provider Action Required

Denial Risk

Do not expect coverage for functional NMES

Coverage is denied because functional neuromuscular electrical stimulation using any device is considered investigational for all indications. This includes devices requested for spinal cord injury ambulation, restoration of upper- or lower-extremity function after nerve damage or stroke, foot drop related to congenital disorders or nerve damage, or treatment of pain.

Denial Risk

All indications remain investigational

Functional NMES is considered investigational for all indications, including spinal cord injury, stroke, congenital disorders, nerve damage, pain, and other conditions; requests may therefore be denied as investigational. NMES cycling is also subject to this policy because its feasibility and long-term health benefits remain uncertain.

Technology Background

Functional neuromuscular electrical stimulation uses an orthotic device and microprocessor-controlled electrical stimulation to activate peripheral nerves and produce functional movements such as sitting, standing, walking, and grasping. Systems may use surface or implanted electrodes and may operate as closed-loop systems that adjust stimulation based on muscle force and joint position.

Key Definitions

Functional neuromuscular electrical stimulation

DefinitionA method being developed to restore function in patients with damaged or destroyed nerve pathways through an orthotic device with microprocessor-controlled electrical neuromuscular stimulation.

Included stimulation modalities

NMESNeuromuscular electrical stimulation.

FNSFunctional neuromuscular stimulation.

FESFunctional electrical stimulation.

ENSElectrical neuromuscular stimulation.

EMG-triggered stimulation

Medical Necessity Determination

Functional Neuromuscular Electrical Stimulation Equipment

No functional neuromuscular electrical stimulation device is covered because the technology is considered investigational for all indications.

No covered DME indication: The requested equipment is a functional neuromuscular electrical stimulation device or related system, and the policy considers this technology investigational for all indications.

FDA clearance or premarket approval does not establish coverage under this policy.

Not Covered Services

Any functional neuromuscular electrical stimulation device is not covered when requested for any indication under this policy, including FDA-cleared or FDA-approved devices. This includes requests involving spinal cord injury, stroke, congenital disorders, nerve damage, pain, and other conditions.